STUDY ON FORMULATION, CHARACTERIZATION AND MODIFICATION OF SUSTAINED RELEASE BILAYER MATRIX TABLETS OF PROPRANOLOL HCl AND NIFEDIPINE FOR ANTIHYPERTENSIVE THERAPY
Background: Sustained-release (SR) bilayer matrix tablets allow two release segments, or two drugs, to be combined in one dosage unit. Propranolol hydrochloride (BCS class I) and nifedipine (BCS class II) are complementary antihypertensives, but their contrasting solubility makes the design of a shared SR system challe...